Abstract
There is a crisis in preclinical research involving laboratory animals. Too many experiments, in all disciplines, have been found to give results which turn out to be irreproducible. And, unfortunately, the results of clinical trials of potential treatments of traumatic brain injury (TBI), suggested by extensive animal research, have so far been disappointing. Faulty experimental design could be one of several possible causes. This chapter briefly covers the basic principles of experimental design, with emphasis on completely randomized, randomized block (cohort), and factorial designs. The determination of sample size is discussed together with some aspects of the statistical analysis and presentation of the results. The Standardized Effect Size (Cohen’s d) is introduced as a description of the magnitude of a response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Begley CG, development ELMD (2012) Raise standards for preclinical cancer research. Nature 483(7391):531–533
Prinz F, Schlange T, Asadullah K (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10(9):712
Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N et al (2008) Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler 9(1):4–15
Freedman LP, Cockburn IM, Simcoe TS (2015) The economics of reproducibility in preclinical research. PLoS Biol 13(6):e1002165
Bebarta V, Luyten D, Heard K (2003) Emergency medicine animal research: does use of randomization and blinding affect the results? Acad Emerg Med 10(6):684–687
Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES et al (2013) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14(5):365–376
Fisher RA (1960) The design of experiments. Hafner Publishing Company, Inc, New York
Hill AB (1967) Principles of medical statistics, 8th edn. The Lancet, London
Festing MFW (2016) The design of animal experiments, 2nd edn. Sage Publications, Thousand Oaks
Teng SX, Katz PS, Maxi JK, Mayeux JP, Gilpin NW, Molina PE (2015) Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation. Brain Behav Immun 45:145–156
Russell WMS, Burch RL (1959) The principles of humane experimental technique, special edition. Universities Federation for Animal Welfare, Potters Bar, England
Cox DR, Reid N (2000) The theory of the design of experiments. Chapman and Hall/CRC, Boca Raton, FL
Mead R (1988) The design of experiments. Cambridge University Press, Cambridge, NY
Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, NJ
Zhang C, Chen J, Lu H (2015) Expression of aquaporin-4 and pathological characteristics of brain injury in a rat model of traumatic brain injury. Mol Med Rep 12(5):7351–7357
Kilkenny C, Altman DG (2010) Improving bioscience research reporting: ARRIVE-ing at a solution. Lab Anim 44(4):377–378
Lin YP, Jiang RC, Zhang JN (2015) Stability of rat models of fluid percussion-induced traumatic brain injury: comparison of three different impact forces. Neural Regen Res 10(7):1088–1094
Festing MFW (2016) Genetically defined strains in drug development and toxicity testing. In: Proetzel, Wiles MV (eds) Mouse models of drug discovery, 2nd edn. Humana, New York, pp 1–17
Festing MFW (1972) Mouse strain identification. Nature 238:351–352
Schwartz WJ, Zimmerman P (1990) Circadian timekeeping in BALB/c and C57BL/6 inbred mouse strains. J Neurosci 11:3685–3694
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160(7):1577–1579
Ellis PD (2010) The essential guide to effect sizes. Cambridge University Press, Cambridge
Cumming G (2012) Understanding the new statistics. Routledge, Abingdon. 12 A.D.
Festing MFW (2014) Extending the statistical analysis and graphical presentation of toxicity test results using standardized effect sizes. Toxicol Pathol 42(8):1238–1249. https://doi.org/10.1177/0192623313517771
Stein DG (2015) Embracing failure: what the phase III progesterone studies can teach about TBI clinical trials. Brain Inj 29(11):1259–1272
Jin H, Li W, Dong C, Ma L, Wu J, Zhao W (2016) Effects of different doses of levetiracetam on aquaporin 4 expression in rats with brain Edema following fluid percussion injury. Med Sci Monit 22:678–686
Acknowledgment
I thank Dr. Johnny Lifshitz for helpful advice in the preparation of this chapter.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Appendix
Appendix
An example of a possible protocol for testing a proposed treatment using a randomized block/cohort design. This could easily be modified to investigate different treatments or times.
The protocol might have two factors “Treatment” and “Time following treatment.”
Four treatments might be:
-
1.
Sham
-
2.
TBIÂ +Â vehicle
-
3.
TBIÂ +Â Treatment-low dose
-
4.
TBIÂ +Â Treatment-high dose
The factor “Time” might have two levels, say 12 h and 48 h following the treatments.
Each block/cohort would therefore involve eight animals (4 treatments × 2 times post treatment).
Six of the rats in each block would have TBI and two would be shams. It is assumed that the treatments could be done conveniently in one day.
Various outcomes could be measured in the live animals including, say, a “neural sensitivity score,” and other types of behavior. It is assumed that all eight rats in a block could be measured in a relatively short period. Histological and anatomical outcomes would be made after the animals are euthanized at the two time points.
With, say, five blocks/cohorts the protocol would involve 40 animals. In this case the ANOVA table to be used for all the outcome variables such as behavior and brain water content would be as follows:
Source | DF |
---|---|
Blocks | 4 |
Treatments | 3 |
Times | 1 |
Trt. × Time | 3 |
Error | 28 |
Total | 39 |
In the absence of a Treatment × Time interaction sample sizes for comparing the four groups will be n = 10. If a power analysis justification is needed for that sample size, the SES for a sample size of 10 can be looked in Table 3. It is 1.53 SDs. This is the predicted detectable effect size in units of standard deviations. So multiplied by the SD of a character, it predicts the effect size in original units that the experiment will be able to detect for a 90% power and a 5% significance level. The sample size for comparing the times will be N = 20. This with 28 degrees of freedom in the error term will provide plenty of power. If a Treatment × Time interaction is detected it implies that the observed treatment differences are not equally valid at the two time points. An experiment like this one is really much more powerful than suggested by these sample sizes because there is a much better estimate of the error (28 DF) which is above the suggested maximum using the Resource Equation method.
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Festing, M.F.W. (2018). The Principles of Experimental Design and the Determination of Sample Size When Using Animal Models of Traumatic Brain Injury. In: Srivastava, A., Cox, C. (eds) Pre-Clinical and Clinical Methods in Brain Trauma Research. Neuromethods, vol 139. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8564-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8564-7_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8563-0
Online ISBN: 978-1-4939-8564-7
eBook Packages: Springer Protocols